AAVantgarde BioListed
No domain yetbiotech_life_sciences
AAVantgarde is a clinical stage, biotechnology company advancing best-in-class therapies for patients with inherited retinal diseases (IRDs). With a strong foundation in translati…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
AAVantgarde is a clinical stage, biotechnology company advancing best-in-class therapies for patients with inherited retinal diseases (IRDs). With a strong foundation in translati…
AM-Pharma is a biopharmaceutical company focused on the preclinical and clinical development of recombinant human Alkaline Phosphatase (recAP) as a treatment for Acute Kidney Inju…
Amphista Therapeutics is a UK-based biotech company focused on targeted protein degradation to develop new treatments for diseases. The company aims to create first-class therapeu…
Anaveon is a late stage preclinical biotech company focused on developing engineered antibodies that target central regulatory nodes of the immune system to treat autoimmune disea…
Azafaros is a clinical-stage company focused on developing therapies for severe rare metabolic disorders, particularly lysosomal storage disorders. Their lead program, nizubaglust…
Beacon Therapeutics is a clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases. The Company is har…
Bicycle Therapeutics is developing precision-guided therapeutics to target solid tumors and other hard-to-treat conditions using their proprietary phage display-screening platform.
BioInvent is a clinical-stage company that discovers and develops antibodies for cancer therapy, focusing on innovative immuno-oncology drug candidates.
Braveheart Bio is focused on transforming the care of hypertrophic cardiomyopathy (HCM) through innovative treatments like BHB-1893, a cardiac myosin inhibitor aimed at improving…
Calluna Pharma is a global clinical-stage biotechnology company pioneering a breakthrough approach to treating inflammatory and fibrotic diseases by leveraging the body’s innate i…
CaMaRa is an open-source project within the Linux Foundation focused on defining, developing, and testing APIs that simplify telco network capabilities, enabling seamless access a…
cAMPfield Therapeutics is a clinical-stage biopharmaceutical company focused on developing well-tolerated and highly effective oral medicines for inflammatory bowel disease (IBD).
CatalYm is pioneering the neutralization of GDF-15 to overcome cancer therapy resistance, developing safe and efficacious immune therapies for solid tumors, particularly focusing…
CellCentric is a clinical-stage biopharmaceutical company focused on the development of a first-in-class oral p300/CBP inhibitor to treat multiple myeloma and other cancer types.
Citryll is a biotech company developing innovative therapies for immune-mediated inflammatory diseases by targeting Extracellular Traps. It raised EUR 85 million in Series B fundi…
Complement Therapeutics is a clinical-stage biotechnology company advancing precision therapies for complement-mediated diseases, focusing initially on geographic atrophy, an adva…
Corsera Health is redefining the future of health by enabling earlier prediction of atherosclerotic cardiovascular disease (ASCVD) and developing a once-annual RNAi medicine to pr…
Coultreon Biopharma is focused on developing life-changing medicines for patients affected by chronic inflammatory diseases, leveraging expertise in immunology and drug discovery…
A biotechnology company developing nucleic acid therapies for rare diseases.
EEDEN is a German recycling-technology company that has developed a proprietary chemical process to address textile waste, focusing on recycling cotton-polyester blended fabrics i…
Elevara Medicines is a clinical-stage biotechnology company focused on developing innovative therapies for rheumatoid arthritis (RA) and chronic inflammatory diseases. The company…
enGene Therapeutics Inc. is a clinical-stage biotechnology company based in Montreal, Canada, that specializes in non-viral genetic medicines. It aims to mainstream gene therapy t…
Engrail Therapeutics is a clinical-stage pharmaceutical company focused on developing innovative, precision-targeted therapeutics for neuropsychiatric and neurodevelopmental disor…
Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases.
Expedition Therapeutics is a biotech company developing treatments for inflammatory and respiratory diseases, including COPD. The company's lead drug, EXPD-101, targets neutrophil…
F2G is focused on developing first-in-class medicines to treat rare, life-threatening fungal infections using a proprietary genomic technology platform.
Gate Bioscience is creating a new class of small molecule therapeutics called Molecular Gates, which selectively eliminate harmful extracellular proteins linked to diseases.
Genomines enhances plants' natural biology to renewably mine nickel and other metals, providing a sustainable alternative to traditional mining methods.
Granite Bio is a biotechnology company developing first-in-class antibodies targeting the root causes of inflammatory, autoimmune, and fibrotic diseases.
Kynexis is advancing a potential first-in-class approach to restore cognitive function for people living with brain diseases. The company is developing KYN-5356, a first-in-class…
We are developing small molecule somatic expansion inhibitors for the treatment of Huntington’s Disease and other triplet repeat expansion diseases. Our approach has the potential…
A clinical-stage biopharma company based in California, focused on therapies for CNS disorders. The company employs proprietary technologies including optogenetics, STARmap and tr…
Marea Therapeutics is focused on developing next-generation medicines for cardioendocrine diseases by leveraging large-scale human genetic data and advancements in biology.
Memento Medicines is a biotech company dedicated to developing new therapies for patients with retinal diseases, focusing on novel antibody therapies. Its lead program, MMT-205, i…
Mestag is an immunology company driving first-in-class treatments for cancer and inflammatory diseases. Through our unique understanding of fibroblast biology, we are rapidly adva…
Mosanna is developing an easy-to-use nighttime nasal spray to help restore the body’s natural airway control for obstructive sleep apnea patients.
Navigator Medicines is a clinical-stage biotech advancing bispecific antibodies to bring new hope to people living with complex inflammatory disorders and autoimmune diseases.
NeRRe Therapeutics is a private, UK-based clinical-stage company focused on developing neurokinin receptor antagonists for treating chronic and debilitating conditions caused by n…
NewAmsterdam Pharma is a biopharmaceutical company focused on developing treatments for metabolic diseases, particularly cardiovascular disease. It investigates obicetrapib for lo…
Noema Pharma is a clinical-stage biotech developing a late-stage portfolio of oral small molecule therapeutics with well-characterized mechanisms and unique features aimed at deli…
NorthSea Therapeutics B.V. is a late-stage clinical biotechnology company developing novel and innovative strategies for the treatment of metabolic, cholestatic and fibrotic disea…
Novameat is a Barcelona-based company in the food and beverage manufacturing industry that develops plant-based protein cuts for food makers. The company combines natural ingredie…
Numab is a Swiss biotechnology company with more than a decade of experience advancing multispecific therapeutics. Our scientific expertise and proprietary technologies enable sop…
OMEICOS Therapeutics is a clinical-stage biopharmaceutical company focused on developing a novel class of synthetic bioactive lipid mediators for the treatment of cardiovascular,…
Orbis Medicines is developing a platform to discover, develop, and deliver drug candidates for challenging targets, focusing on oral biologics through AI-driven chemical innovatio…
Pact is a platform that helps teams build what clients envision, providing context and understanding to turn client visions into actionable infrastructure.
Pheon Therapeutics is a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of hard-to-treat cancers.
PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single doma…
Prilenia is dedicated to developing new treatments for the urgent needs facing patients and families with Huntington’s disease, amyotrophic lateral sclerosis (ALS), and other neur…
Progentos is developing first-in-class compounds to induce endogenous oligodendrocyte progenitor cells to remyelinate axons in patients suffering from Multiple Sclerosis (MS) and…
Protego Health develops software for healthcare revenue cycle management focused on reducing medical claim denials. The platform integrates payer-specific policies and coding guid…
Purespring is a precision nephrology company pioneering podocyte-targeted, genetically-driven therapies for kidney diseases.
Replimune is a biotech company focused on revolutionizing cancer treatment with a new class of oncolytic immunotherapies intended to activate a powerful and durable full-body anti…
RyCarma is a clinical-stage biotech company developing first-in-class small molecule therapeutics for skeletal muscle and cardiovascular diseases. Our drug discovery platform is b…
Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach of reprogramming recombinases. The company is applying its proprietary know-how to dev…
Slate Medicines is focused on advancing next-generation therapeutics for migraine and other headache disorders, addressing the significant disability and disease burden faced by p…
Sling Therapeutics, Inc., is a biopharmaceutical company focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease (TED). The company is…
SOLASTA Bio is an ambitious bioinsecticides start up with a unique proposition: nature-inspired small molecule insect control products for the global agricultural market.
Solstice Oncology is a biotech company focused on developing a next-generation anti-CTLA-4 antibody for oncology treatments, with exclusive global rights (ex-China) to the clinica…
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted cardiometabolic therapeutics to improve outcomes for patients struggling with type 2 diab…
SynOx Therapeutics is a clinical-stage company focused on developing emactuzumab, a differentiated, next-generation monoclonal antibody targeting CSF-1R, for the treatment of teno…
Tessellate Bio is a biotechnology company focusing on novel synthetic lethality approaches beyond Homologous Recombination Deficiency (HRD). We are discovering and developing new…
Tropic Biosciences develops enhanced varieties of tropical crops through advanced genetic innovation, utilizing gene editing technologies like CRISPR and its proprietary GEiGS® pl…
VectorY is pioneering vectorized antibody therapies to reverse the course of neurodegenerative disease, with a strong pipeline of potentially disease-modifying treatments for ALS,…
Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes v…
Vor Bio is advancing therapies that aim to correct autoimmune disease biology, moving beyond symptom control toward lasting improvement. Their lead program, telitacicept, is a fir…
RQ Biotechnology is making instant immunity a reality for vulnerable people. As the leading passive immunization discovery company, we partner with pharmaceutical companies to dev…
Altesa is an innovative, clinical-stage pharmaceutical company dedicated to preventing and treating the leading cause of COPD and asthma exacerbations -- namely viral respiratory…
Rectify Pharma develops Positive Functional Modulators (PFMs), a novel class of disease-modifying oral, small molecules designed to rectify membrane protein dysfunction linked to…
AIRNA is committed to delivering the promise of RNA editing to people with rare diseases and common conditions, developing novel medicines with the potential to deliver functional…
Mariana Oncology, a Novartis company, is pioneering novel radioligand therapies designed to optimize cancer treatment efficacy while minimizing side effects for patients.
At Aiolos Bio, we are dedicated to revolutionizing the treatment landscape for respiratory disease and other immunological disorders. Our goal is to provide patients and caregiver…